Minnesota HF3054 modifies prescription drug transparency provisions.

Minnesota HF3054 amends existing statutes to modify prescription drug transparency provisions. The bill requires manufacturers, pharmacies, pharmacy benefit managers, and wholesale drug distributors to report specific drug information to the commissioner of health. This includes details such as drug descriptions, acquisition costs, sales revenue, and rebate amounts. The commissioner must then post this information on the department's website or through a contracted entity.

Minnesota HF3054 modifies prescription drug transparency provisions.

Minnesota HF3054 amends existing statutes to modify prescription drug transparency provisions. The bill requires manufacturers, pharmacies, pharmacy benefit managers, and wholesale drug distributors to report specific drug information to the commissioner of health. This includes details such as drug descriptions, acquisition costs, sales revenue, and rebate amounts. The commissioner must then post this information on the department's website or through a contracted entity.